Finterest Raises $1.5 Million Seed Round to Build Crypto Lending Protocol
Investors Include Polychain and 9Yards Capital to Support Finterest’s Mission of Bringing Transparency to the…
Investors Include Polychain and 9Yards Capital to Support Finterest’s Mission of Bringing Transparency to the…
RIVERWOODS, Ill.–(BUSINESS WIRE)–#fortune500–Foundry’s Computerworld announces Discover as a 2023 Best Places to Work in IT….
ROANOKE, Va.–(BUSINESS WIRE)–KlariVis, a fast-growing enterprise dashboard and analytics solution for the financial services industry,…
APM Reliability helps reduce unplanned downtime by predicting equipment issues before they occur The installation…
The company unveils its new brand identity and product offerings to establish a fresh approach…
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Informatica® (NYSE: INFA), an enterprise cloud data management leader announced that it…
CHICAGO & LONDON–(BUSINESS WIRE)–#affordablehousing–Northern Trust today announced its first global Charity Trading Day, benefiting global…
More than two million clinicians around the world trust and depend on UpToDate to help…
Rents are growing at half the pace they were in the summer and are expected…
The state’s Division of Medicaid and Department of Human Services to deploy Verato’s next-generation healthcare…
The end-to-end solution utilizes Azure digital twin technology to reduce carbon footprint and increase efficiency…
Aetrex will debut its Albert 3DFit foot scanning technology and Foot.com 3D Data Portal for…
New SASE service standard accelerates managed service providers’ ability to offer robust, unified network and…
Leading Diagnostic Healthcare Company Announces Development of and Provisional Patent Filing on First-of-Its-Kind Point-of-Care Ophthalmological…
The MEAI-based proprietary compound is aimed at treating Alcohol Use Disorder Tel Aviv, Israel /…
– US board-certified medical oncologist with extensive global clinical and regulatory experience advancing oncology medicines…
GFH009 is First CDK9 Inhibitor Monotherapy to Achieve Compete Response in Acute Myeloid Leukemia Anticancer…
SAB brings extensive expertise in precision oncology, drug development, and early phase clinical trials NEW…
Company’s Second Netherton Syndrome Clinical Study has been Cleared by FDA to Initiate Testing All…
Steven Tuch, Chief Financial Officer Steven Tuch, Chief Financial Officer Steven Tuch, Chief Financial Officer…